Live broadcast of session on biosimilars and EU regulation: still time to join us!
On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role ...
On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role ...
The store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts, ...
ViiV Healthcare presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq ...
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its ...
The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the ...
Shire plc announced it has agreed to license global rights to all indications for PF-00547659 from Pfizer Inc. ...
ViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg ...
Merck, a leading science and technology company, announced an increased commitment to its corporate venture fund under the new Merck ...
GlaxoSmithKline and Innoviva, Inc announced that GlaxoSmithKline plc (GSK) presented new data at the American Thoracic Society (ATS) Conference from ...
Allergan plc launched IBSDonTract.com, an online resource for those living with irritable bowel syndrome with diarrhea (IBS-D). IBS-D, which affects ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
